Pembrolizumab trials for Melanoma (Skin Cancer)

All Pembrolizumab trials · All Melanoma (Skin Cancer) trials

Phase breakdown

Recruiting trials studying Pembrolizumab for Melanoma (Skin Cancer)

• A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.
  NCT07448831 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
  NCT06624644 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma
  NCT07349303 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
  NCT07287917 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations

Common questions

How many trials study Pembrolizumab for Melanoma (Skin Cancer)?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.